Application Software in Dosage Adjustment for Advanced Cancer Patients With Pain

Cancer Institute and Hospital, Chinese Academy of Medical Sciences200 enrolled

Overview

The purpose of this trial is to determine whether Application (APP) would help clinical doctors to adjust the dose of Oxycodone Hydrochloride Prolonged-release Tablets in advanced patients with cancer pain.

Study Type

INTERVENTIONAL

Allocation

Purpose

TREATMENT

Masking

NONE

Enrollment

200

Conditions

Pain Physicians Oxycodone

Interventions

APP softwareDEVICE

A software used to by physicians to adjust the dose of Oxycodone Hydrochloride Prolonged-release Tablets for advanced patient's with cancer pain

Eligibility

Sex: ALLMin age: 18 YearsMax age: 70 Years

Medical Language ↔ Plain English

Inclusion Criteria: * a histologically confirmed diagnosis of Cancer or Sarcoma * advanced patients with severe cancer pain(score \>3) * having used or expected to use the Oxycodone Hydrochloride Prolonged-release Tablets Exclusion Criteria: * allergic to Oxycodone Hydrochloride Prolonged-release Tablets, or other reasons (determined by clinical doctors) unable to use the Opioids

Locations (1)

Cancer Hospital, Chinese Academy of Medical Sciences

Beijing, Beijing Municipality, China

RECRUITING

Outcomes

Primary Outcomes

Numerical Pain Rating Scale

Time frame: upto 8 months

Central Contacts

Peng Liu, MD

CONTACT

8610-87788405 13910216310@163.com

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.